Parallax Volatility Advisers
PACB icon

Parallax Volatility Advisers’s Pacific Biosciences PACB Stock Holding History

Parallax Volatility Advisers’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-100
Closed -$981 – 2217
2023
Q4 		$981 Buy
+100
New +$818 ﹤0.01% 2092
2023
Q1 		– Sell
-100
Closed -$818 – 3051
2022
Q4 		$818 Sell
100
-599,900
-100% -$5.17M ﹤0.01% 2755
2022
Q3 		$3.48M Buy
+600,000
New +$3.44M 0.01% 1168
2022
Q1 		– Sell
-10,800
Closed -$221K – 3056
2021
Q4 		$221K Buy
10,800
+10,700
+10,700% +$258K ﹤0.01% 1627
2021
Q3 		$3K Sell
100
-91,400
-100% -$2.71M ﹤0.01% 1949
2021
Q2 		$3.2M Buy
91,500
+76,200
+498% +$2.22M ﹤0.01% 778
2021
Q1 		$510K Buy
+15,300
New +$536K ﹤0.01% 953
2018
Q2 		– Sell
-15,000
Closed -$31K – 2938
2018
Q1 		$31K Hold
15,000
– – ﹤0.01% 1649
2017
Q4 		$40K Buy
+15,000
New +$52.5K ﹤0.01% 3334

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Parallax Volatility Advisers's PACB Position: Q1 2023 in Review

Parallax Volatility Advisers sold out of Pacific Biosciences (PACB) in Q1 2023, closing a stake of 993 shares — an estimated $8.12K sold.

Parallax Volatility Advisers first reported a position in PACB in Q4 2017 and held it in 7 quarters. The position peaked at $1.05M in Q3 2022. 259 funds tracked by Wall St. Rank hold PACB as of Q1 2023.

  • Parallax Volatility Advisers reported no remaining Pacific Biosciences position as of Q1 2023 after selling out during the quarter.
  • Parallax Volatility Advisers sold 993 Pacific Biosciences shares in Q1 2023, an estimated $8.12K.
  • Parallax Volatility Advisers first reported a position in Pacific Biosciences in Q4 2017 and held it in 7 quarters.
  • Parallax Volatility Advisers's Pacific Biosciences position peaked at $1.05M in Q3 2022.
  • 259 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2023.

Based on Parallax Volatility Advisers's 13F filing for Q1 2023, filed 15 May 2023.